Efficacy of Capecitabine With Adjuvant Radiotherapy in Treatment of Early Stages Breast Cancer (Retrospective Study).
NCT04815616 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 47
Last updated 2023-02-01
Summary
1- Determine the efficacy and safety of concurrent capecitabine and external beam irradiation in patients with early stages breast cancer.
Conditions
Interventions
- RADIATION
-
Radiotherapy
Capecitabine with adjuvant radiotherapy in treatment of Early Stages Breast Cancer
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-04-01
- Primary Completion
- 2023-04-01
- Completion
- 2023-04-01
More Related Trials
-
Letrozole Plus Metronomic Capecitabine as First-line Treatment for Patients With Recurrent or Metastatic Breast Cancer
NCT04942899 ·Status: UNKNOWN ·Phase: PHASE2
-
Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer
NCT00153907 ·Status: COMPLETED ·Phase: PHASE1
-
Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study
NCT00263705 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer
NCT02253459 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing UTD2 Combined With Capecitabine to Capecitabine as Adjuvant Therapy for Non-pCR TNBC Patients
NCT07021261 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Capecitabine in the Treatment of Breast Cancer With Low-hormone Receptor Expression After Neoadjuvant Chemotherapy
NCT03821454 ·Status: UNKNOWN ·Phase: NA
-
Sequential Neo-adjuvant Chemotherapy Followed by Capecitabine Vs. Conventional Adjuvant Chemotherapy in Breast Cancer
NCT03011060 ·Status: UNKNOWN ·Phase: PHASE3
-
Capecitabine in Low Risk Triple Negative Breast Cancer
NCT06787339 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer
NCT05063136 ·Status: RECRUITING ·Phase: PHASE3
-
Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
NCT05288777 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Effect of Capivasertib on ctDNA in ER Positive Breast Cancer
NCT06613516 ·Status: WITHDRAWN ·Phase: PHASE2
-
Irinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast Cancer
NCT01501669 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Capecitabine Metronomic Chemotherapy to Triple-negative Breast Cancer
NCT01112826 ·Status: COMPLETED ·Phase: PHASE3
-
Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast Cancer
NCT01924078 ·Status: UNKNOWN ·Phase: PHASE2
-
UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases
NCT05535413 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine
NCT00156312 ·Status: COMPLETED ·Phase: NA
-
PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast Cancer
NCT05052437 ·Status: COMPLETED ·Phase: PHASE1
-
Capecitabine Versus Vinorelbine in High Risk Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy
NCT03703427 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Adjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast Cancer
NCT05861271 ·Status: RECRUITING ·Phase: PHASE2
-
BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer
NCT00540800 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase Ⅱ Study of an All-Oral Combination of Low-dose Etoposide/Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and/or Taxanes
NCT01589159 ·Status: COMPLETED ·Phase: PHASE2
-
First Line Therapy for Patients With Metastatic Breast Cancer
NCT00456846 ·Status: TERMINATED ·Phase: PHASE2
-
Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer
NCT02767661 ·Status: COMPLETED ·Phase: PHASE3
-
Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)
NCT01126138 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison of Neo-adjuvant Weekly Paclitaxel With or Without Carboplatin in Early Breast Cancer
NCT00919880 ·Status: COMPLETED ·Phase: PHASE2